This updated EML aligns with the 23rd WHO Model List of Essential Medicines, incorporating the latest scientific evidence and global best practices. It serves as a crucial tool for healthcare providers, policymakers, and procurement agencies, guiding the selection and rational use of medicines across the country.
Key Features of the 7th Edition EML:
- Expanded Therapeutic Categories: The list now includes new medicines and dosage forms to address Ethiopia’s evolving public health needs.
- Removal of Ineffective Medicines: Medicines with safety, efficacy, and cost concerns have been removed to enhance efficiency and effectiveness.
- Antimicrobial Stewardship: The inclusion of WHO Access, Watch, Reserve (AWaRe) classification strengthens antimicrobial stewardship and combats antimicrobial resistance.
- Alignment with Clinical Guidelines: The revision aligns with updated national and global clinical guidelines, ensuring evidence-based decision-making.
“For nearly four decades, Ethiopia has continuously updated its Essential Medicines List to reflect scientific advancements and national health priorities,” said Mr. Seyoum Wolde, Deputy Director General, Medicines sector, EFDA. “This latest revision is a testament to the country’s dedication to achieving Universal Health Coverage (UHC) and improving health outcomes.”
Dr. Bejoy P. Nambiar, Coordinator-Strategic Health Policy and Planning Team Lead-UHC Cluster (Health Systems, Healthier Populations) at the WHO Ethiopia Country Office, stated, “The 7th Edition of the Ethiopian Essential Medicines List ensures that healthcare providers have access to the most relevant and effective treatments. It is an important step in strengthening Ethiopia’s healthcare system, enhancing patient care, and optimizing the use of available resources.”
The revision process was inclusive and evidence-based, involving extensive stakeholder consultations and a multidisciplinary team of experts. The European Union Civil Protection and Humanitarian Aid Operations (ECHO) provided crucial financial support for the revision and implementation of the EML.
The successful implementation of the 7th Edition EML requires strong collaboration among all stakeholders, including healthcare providers, policymakers, regulators, and development partners. The WHO and other stakeholders reaffirm their commitment to supporting Ethiopia in pharmaceutical governance, supply chain strengthening, and policy implementation.
